tRNA Dosage Shifts Prostate Cancer Lineage and Therapy Resistance
A new study identifies tRNA1Arg(UCU) as a key regulator of lineage plasticity in prostate cancer. Its downregulation drives resistance to androgen receptor inhibitors, while restoration restores sensitivity. This mechanism links translational control to tumor evolution and patient survival.